Vivo Opportunity, LLC - 23 Dec 2022 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
10%+ Owner
Signature
/s/ Gaurav Aggarwal, as a managing member of Vivo Opportunity, LLC
Issuer symbol
TERN
Transactions as of
23 Dec 2022
Net transactions value
+$5,499,995
Form type
4
Filing time
23 Dec 2022, 16:48:58 UTC
Previous filing
08 Sep 2022
Next filing
15 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TERN Common Stock Purchase $5,499,995 +758,620 +21% $7.25 4,340,212 23 Dec 2022 By Vivo Opportunity Fund Holdings, L.P. F1
holding TERN Common Stock 2,036,557 23 Dec 2022 By: Vivo Capital Fund VIII, L.P.
holding TERN Common Stock 281,223 23 Dec 2022 By: Vivo Capital Surplus Fund VIII, L.P.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P., the record holder of the securities. Gaurav Aggarwal, Hongbo Lu, Kevin Dai, Frank Kung and Michael Chang are managing members of Vivo Opportunity, LLC and may be deemed to share voting and dispositive power over the securities held by Vivo Opportunity Fund Holdings, L.P. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his or her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.